nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—Pindolol—hypertension	0.156	0.506	CrCtD
Nadolol—Penbutolol—hypertension	0.153	0.494	CrCtD
Nadolol—ADRB1—hypertension	0.0686	0.543	CbGaD
Nadolol—ADRB2—hypertension	0.0577	0.457	CbGaD
Nadolol—ADRB3—Labetalol—hypertension	0.0206	0.083	CbGbCtD
Nadolol—Levobunolol—Timolol—hypertension	0.0185	0.0896	CrCrCtD
Nadolol—ADRB3—Pindolol—hypertension	0.0175	0.0705	CbGbCtD
Nadolol—Penbutolol—Timolol—hypertension	0.0168	0.0816	CrCrCtD
Nadolol—Carteolol—Pindolol—hypertension	0.0161	0.078	CrCrCtD
Nadolol—Levobunolol—Pindolol—hypertension	0.0161	0.078	CrCrCtD
Nadolol—Levobunolol—Penbutolol—hypertension	0.0157	0.0762	CrCrCtD
Nadolol—Carteolol—Penbutolol—hypertension	0.0157	0.0762	CrCrCtD
Nadolol—Bupranolol—Timolol—hypertension	0.0134	0.0648	CrCrCtD
Nadolol—Bupranolol—Pindolol—hypertension	0.0116	0.0564	CrCrCtD
Nadolol—Bupranolol—Penbutolol—hypertension	0.0114	0.0551	CrCrCtD
Nadolol—ADRB2—Esmolol—hypertension	0.0111	0.0448	CbGbCtD
Nadolol—ADRB1—Esmolol—hypertension	0.0109	0.0441	CbGbCtD
Nadolol—Pindolol—Acebutolol—hypertension	0.0105	0.0508	CrCrCtD
Nadolol—ADRB3—Timolol—hypertension	0.01	0.0405	CbGbCtD
Nadolol—Carteolol—Propranolol—hypertension	0.00985	0.0477	CrCrCtD
Nadolol—Levobunolol—Propranolol—hypertension	0.00985	0.0477	CrCrCtD
Nadolol—ADRB3—Carvedilol—hypertension	0.00973	0.0392	CbGbCtD
Nadolol—Pindolol—Metoprolol—hypertension	0.00952	0.0461	CrCrCtD
Nadolol—Pindolol—Esmolol—hypertension	0.00902	0.0437	CrCrCtD
Nadolol—Penbutolol—Propranolol—hypertension	0.00896	0.0434	CrCrCtD
Nadolol—ADRB3—Propranolol—hypertension	0.00895	0.0361	CbGbCtD
Nadolol—ADRB2—Nebivolol—hypertension	0.00841	0.0339	CbGbCtD
Nadolol—ADRB2—Labetalol—hypertension	0.00841	0.0339	CbGbCtD
Nadolol—ADRB1—Nebivolol—hypertension	0.00828	0.0334	CbGbCtD
Nadolol—ADRB1—Labetalol—hypertension	0.00828	0.0334	CbGbCtD
Nadolol—Pindolol—Betaxolol—hypertension	0.00794	0.0385	CrCrCtD
Nadolol—ADRB2—Acebutolol—hypertension	0.00769	0.031	CbGbCtD
Nadolol—ADRB1—Acebutolol—hypertension	0.00757	0.0306	CbGbCtD
Nadolol—ADRB2—Metoprolol—hypertension	0.00715	0.0288	CbGbCtD
Nadolol—ADRB2—Pindolol—hypertension	0.00715	0.0288	CbGbCtD
Nadolol—ADRB1—Pindolol—hypertension	0.00704	0.0284	CbGbCtD
Nadolol—ADRB1—Metoprolol—hypertension	0.00704	0.0284	CbGbCtD
Nadolol—ADRB2—Betaxolol—hypertension	0.00637	0.0257	CbGbCtD
Nadolol—ADRB1—Betaxolol—hypertension	0.00628	0.0253	CbGbCtD
Nadolol—ADRB2—Penbutolol—hypertension	0.00583	0.0235	CbGbCtD
Nadolol—ADRB1—Penbutolol—hypertension	0.00574	0.0232	CbGbCtD
Nadolol—Pindolol—Propranolol—hypertension	0.00539	0.0261	CrCrCtD
Nadolol—ADRB2—Timolol—hypertension	0.00411	0.0166	CbGbCtD
Nadolol—ADRB1—Timolol—hypertension	0.00404	0.0163	CbGbCtD
Nadolol—ADRB2—Carvedilol—hypertension	0.00398	0.016	CbGbCtD
Nadolol—ADRB1—Carvedilol—hypertension	0.00392	0.0158	CbGbCtD
Nadolol—ADRB2—Propranolol—hypertension	0.00366	0.0148	CbGbCtD
Nadolol—ADRB1—Propranolol—hypertension	0.0036	0.0145	CbGbCtD
Nadolol—ABCB1—Acebutolol—hypertension	0.00205	0.00826	CbGbCtD
Nadolol—ABCB1—Candesartan—hypertension	0.0019	0.00768	CbGbCtD
Nadolol—ABCB1—Metoprolol—hypertension	0.0019	0.00768	CbGbCtD
Nadolol—ABCB1—Terazosin—hypertension	0.00179	0.00722	CbGbCtD
Nadolol—ABCB1—Reserpine—hypertension	0.0017	0.00684	CbGbCtD
Nadolol—ABCB1—Perindopril—hypertension	0.00155	0.00626	CbGbCtD
Nadolol—ABCB1—Doxazosin—hypertension	0.00149	0.00602	CbGbCtD
Nadolol—ABCB1—Nisoldipine—hypertension	0.00149	0.00602	CbGbCtD
Nadolol—ABCB1—Diltiazem—hypertension	0.00144	0.00582	CbGbCtD
Nadolol—ABCB1—Telmisartan—hypertension	0.00136	0.00547	CbGbCtD
Nadolol—ABCB1—Enalapril—hypertension	0.00129	0.00518	CbGbCtD
Nadolol—ABCB1—Bepridil—hypertension	0.00129	0.00518	CbGbCtD
Nadolol—ABCB1—Lisinopril—hypertension	0.00129	0.00518	CbGbCtD
Nadolol—ABCB1—Prazosin—hypertension	0.00123	0.00495	CbGbCtD
Nadolol—ABCB1—Amlodipine—hypertension	0.00115	0.00465	CbGbCtD
Nadolol—ABCB1—Spironolactone—hypertension	0.00113	0.00456	CbGbCtD
Nadolol—ABCB1—Felodipine—hypertension	0.00111	0.00448	CbGbCtD
Nadolol—ABCB1—Timolol—hypertension	0.00109	0.00441	CbGbCtD
Nadolol—ABCB1—Nifedipine—hypertension	0.00108	0.00434	CbGbCtD
Nadolol—ABCB1—Carvedilol—hypertension	0.00106	0.00427	CbGbCtD
Nadolol—ABCB1—Nicardipine—hypertension	0.00106	0.00427	CbGbCtD
Nadolol—ABCB1—Propranolol—hypertension	0.000974	0.00393	CbGbCtD
Nadolol—ABCB1—Captopril—hypertension	0.000962	0.00388	CbGbCtD
Nadolol—ABCB1—Clonidine—hypertension	0.000929	0.00375	CbGbCtD
Nadolol—ABCB1—Atorvastatin—hypertension	0.000828	0.00334	CbGbCtD
Nadolol—ABCB1—Losartan—hypertension	0.000758	0.00306	CbGbCtD
Nadolol—ABCB1—Verapamil—hypertension	0.000669	0.0027	CbGbCtD
Nadolol—Treprostinil—PTGIR—hypertension	0.000551	0.338	CrCbGaD
Nadolol—Pirbuterol—ADRB1—hypertension	0.000106	0.0649	CrCbGaD
Nadolol—Levobunolol—ADRB1—hypertension	9.43e-05	0.0579	CrCbGaD
Nadolol—Pirbuterol—ADRB2—hypertension	8.9e-05	0.0546	CrCbGaD
Nadolol—Carteolol—ADRB1—hypertension	8.02e-05	0.0492	CrCbGaD
Nadolol—Levobunolol—ADRB2—hypertension	7.93e-05	0.0487	CrCbGaD
Nadolol—Penbutolol—HTR1B—hypertension	7.05e-05	0.0433	CrCbGaD
Nadolol—Bupranolol—ADRB1—hypertension	6.82e-05	0.0418	CrCbGaD
Nadolol—Carteolol—ADRB2—hypertension	6.74e-05	0.0414	CrCbGaD
Nadolol—Salbutamol—ADRB1—hypertension	6.41e-05	0.0393	CrCbGaD
Nadolol—Penbutolol—ADRB1—hypertension	6.24e-05	0.0383	CrCbGaD
Nadolol—Bupranolol—ADRB2—hypertension	5.73e-05	0.0352	CrCbGaD
Nadolol—Salbutamol—ADRB2—hypertension	5.39e-05	0.0331	CrCbGaD
Nadolol—Penbutolol—ADRB2—hypertension	5.24e-05	0.0322	CrCbGaD
Nadolol—Pindolol—HTR1B—hypertension	5.08e-05	0.0312	CrCbGaD
Nadolol—Pindolol—ADRB1—hypertension	4.49e-05	0.0276	CrCbGaD
Nadolol—Pindolol—ADRB2—hypertension	3.78e-05	0.0232	CrCbGaD
Nadolol—Pain—Irbesartan—hypertension	1.05e-05	0.000139	CcSEcCtD
Nadolol—Constipation—Irbesartan—hypertension	1.05e-05	0.000139	CcSEcCtD
Nadolol—Fatigue—Hydrochlorothiazide—hypertension	1.05e-05	0.000139	CcSEcCtD
Nadolol—Body temperature increased—Enalapril—hypertension	1.04e-05	0.000139	CcSEcCtD
Nadolol—Dizziness—Doxazosin—hypertension	1.04e-05	0.000139	CcSEcCtD
Nadolol—Insomnia—Losartan—hypertension	1.04e-05	0.000138	CcSEcCtD
Nadolol—Dyspepsia—Betaxolol—hypertension	1.04e-05	0.000138	CcSEcCtD
Nadolol—Loss of consciousness—Timolol—hypertension	1.04e-05	0.000138	CcSEcCtD
Nadolol—Pain—Hydrochlorothiazide—hypertension	1.04e-05	0.000138	CcSEcCtD
Nadolol—Constipation—Hydrochlorothiazide—hypertension	1.04e-05	0.000138	CcSEcCtD
Nadolol—Decreased appetite—Furosemide—hypertension	1.04e-05	0.000138	CcSEcCtD
Nadolol—Vision blurred—Lisinopril—hypertension	1.04e-05	0.000137	CcSEcCtD
Nadolol—Paraesthesia—Losartan—hypertension	1.04e-05	0.000137	CcSEcCtD
Nadolol—Cough—Timolol—hypertension	1.03e-05	0.000137	CcSEcCtD
Nadolol—Chest pain—Ramipril—hypertension	1.03e-05	0.000137	CcSEcCtD
Nadolol—Dizziness—Fosinopril—hypertension	1.03e-05	0.000137	CcSEcCtD
Nadolol—Fatigue—Furosemide—hypertension	1.03e-05	0.000137	CcSEcCtD
Nadolol—Body temperature increased—Telmisartan—hypertension	1.03e-05	0.000137	CcSEcCtD
Nadolol—Decreased appetite—Betaxolol—hypertension	1.03e-05	0.000137	CcSEcCtD
Nadolol—Dyspnoea—Losartan—hypertension	1.03e-05	0.000136	CcSEcCtD
Nadolol—Dizziness—Eplerenone—hypertension	1.03e-05	0.000136	CcSEcCtD
Nadolol—Vomiting—Indapamide—hypertension	1.03e-05	0.000136	CcSEcCtD
Nadolol—Vomiting—Diltiazem—hypertension	1.03e-05	0.000136	CcSEcCtD
Nadolol—Asthenia—Valsartan—hypertension	1.02e-05	0.000136	CcSEcCtD
Nadolol—Hypertension—Timolol—hypertension	1.02e-05	0.000136	CcSEcCtD
Nadolol—Pain—Furosemide—hypertension	1.02e-05	0.000136	CcSEcCtD
Nadolol—Constipation—Furosemide—hypertension	1.02e-05	0.000136	CcSEcCtD
Nadolol—Fatigue—Betaxolol—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Asthenia—Olmesartan—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Dizziness—Nifedipine—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Rash—Diltiazem—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Rash—Indapamide—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Dermatitis—Diltiazem—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Dermatitis—Indapamide—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Dyspepsia—Losartan—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Vomiting—Carvedilol—hypertension	1.02e-05	0.000135	CcSEcCtD
Nadolol—Dizziness—Verapamil—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Pain—Betaxolol—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Constipation—Betaxolol—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Pruritus—Valsartan—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Dry mouth—Ramipril—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Chest pain—Timolol—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Rash—Carvedilol—hypertension	1.01e-05	0.000134	CcSEcCtD
Nadolol—Dermatitis—Carvedilol—hypertension	1.01e-05	0.000133	CcSEcCtD
Nadolol—Pruritus—Olmesartan—hypertension	1e-05	0.000133	CcSEcCtD
Nadolol—Vomiting—Doxazosin—hypertension	1e-05	0.000133	CcSEcCtD
Nadolol—Decreased appetite—Losartan—hypertension	1e-05	0.000133	CcSEcCtD
Nadolol—Body temperature increased—Captopril—hypertension	1e-05	0.000133	CcSEcCtD
Nadolol—Rash—Doxazosin—hypertension	9.96e-06	0.000132	CcSEcCtD
Nadolol—Fatigue—Losartan—hypertension	9.95e-06	0.000132	CcSEcCtD
Nadolol—Dermatitis—Doxazosin—hypertension	9.95e-06	0.000132	CcSEcCtD
Nadolol—Vomiting—Fosinopril—hypertension	9.92e-06	0.000132	CcSEcCtD
Nadolol—Nausea—Propranolol—hypertension	9.9e-06	0.000131	CcSEcCtD
Nadolol—Oedema—Ramipril—hypertension	9.9e-06	0.000131	CcSEcCtD
Nadolol—Dry mouth—Timolol—hypertension	9.87e-06	0.000131	CcSEcCtD
Nadolol—Pain—Losartan—hypertension	9.87e-06	0.000131	CcSEcCtD
Nadolol—Constipation—Losartan—hypertension	9.87e-06	0.000131	CcSEcCtD
Nadolol—Syncope—Lisinopril—hypertension	9.86e-06	0.000131	CcSEcCtD
Nadolol—Vomiting—Eplerenone—hypertension	9.86e-06	0.000131	CcSEcCtD
Nadolol—Rash—Fosinopril—hypertension	9.84e-06	0.00013	CcSEcCtD
Nadolol—Dermatitis—Fosinopril—hypertension	9.83e-06	0.00013	CcSEcCtD
Nadolol—Vomiting—Nifedipine—hypertension	9.79e-06	0.00013	CcSEcCtD
Nadolol—Rash—Eplerenone—hypertension	9.78e-06	0.00013	CcSEcCtD
Nadolol—Dermatitis—Eplerenone—hypertension	9.77e-06	0.00013	CcSEcCtD
Nadolol—Diarrhoea—Valsartan—hypertension	9.76e-06	0.000129	CcSEcCtD
Nadolol—Asthenia—Clonidine—hypertension	9.76e-06	0.000129	CcSEcCtD
Nadolol—Vomiting—Verapamil—hypertension	9.75e-06	0.000129	CcSEcCtD
Nadolol—Shock—Ramipril—hypertension	9.74e-06	0.000129	CcSEcCtD
Nadolol—Body temperature increased—Perindopril—hypertension	9.73e-06	0.000129	CcSEcCtD
Nadolol—Diarrhoea—Olmesartan—hypertension	9.72e-06	0.000129	CcSEcCtD
Nadolol—Rash—Nifedipine—hypertension	9.71e-06	0.000129	CcSEcCtD
Nadolol—Dermatitis—Nifedipine—hypertension	9.7e-06	0.000129	CcSEcCtD
Nadolol—Body temperature increased—Irbesartan—hypertension	9.69e-06	0.000129	CcSEcCtD
Nadolol—Oedema—Timolol—hypertension	9.67e-06	0.000128	CcSEcCtD
Nadolol—Loss of consciousness—Lisinopril—hypertension	9.67e-06	0.000128	CcSEcCtD
Nadolol—Rash—Verapamil—hypertension	9.66e-06	0.000128	CcSEcCtD
Nadolol—Dermatitis—Verapamil—hypertension	9.66e-06	0.000128	CcSEcCtD
Nadolol—Pruritus—Clonidine—hypertension	9.62e-06	0.000128	CcSEcCtD
Nadolol—Body temperature increased—Hydrochlorothiazide—hypertension	9.62e-06	0.000128	CcSEcCtD
Nadolol—Cough—Lisinopril—hypertension	9.6e-06	0.000127	CcSEcCtD
Nadolol—Nausea—Diltiazem—hypertension	9.58e-06	0.000127	CcSEcCtD
Nadolol—Nausea—Indapamide—hypertension	9.58e-06	0.000127	CcSEcCtD
Nadolol—Hyperhidrosis—Ramipril—hypertension	9.57e-06	0.000127	CcSEcCtD
Nadolol—Asthenia—Trandolapril—hypertension	9.52e-06	0.000126	CcSEcCtD
Nadolol—Shock—Timolol—hypertension	9.52e-06	0.000126	CcSEcCtD
Nadolol—Nausea—Carvedilol—hypertension	9.49e-06	0.000126	CcSEcCtD
Nadolol—Asthenia—Enalapril—hypertension	9.48e-06	0.000126	CcSEcCtD
Nadolol—Body temperature increased—Furosemide—hypertension	9.46e-06	0.000125	CcSEcCtD
Nadolol—Dizziness—Valsartan—hypertension	9.44e-06	0.000125	CcSEcCtD
Nadolol—Anorexia—Ramipril—hypertension	9.43e-06	0.000125	CcSEcCtD
Nadolol—Dizziness—Olmesartan—hypertension	9.39e-06	0.000125	CcSEcCtD
Nadolol—Pruritus—Trandolapril—hypertension	9.39e-06	0.000124	CcSEcCtD
Nadolol—Nausea—Doxazosin—hypertension	9.38e-06	0.000124	CcSEcCtD
Nadolol—Chest pain—Lisinopril—hypertension	9.36e-06	0.000124	CcSEcCtD
Nadolol—Body temperature increased—Betaxolol—hypertension	9.36e-06	0.000124	CcSEcCtD
Nadolol—Hyperhidrosis—Timolol—hypertension	9.35e-06	0.000124	CcSEcCtD
Nadolol—Asthenia—Telmisartan—hypertension	9.35e-06	0.000124	CcSEcCtD
Nadolol—Pruritus—Enalapril—hypertension	9.35e-06	0.000124	CcSEcCtD
Nadolol—Diarrhoea—Clonidine—hypertension	9.31e-06	0.000123	CcSEcCtD
Nadolol—Nausea—Fosinopril—hypertension	9.27e-06	0.000123	CcSEcCtD
Nadolol—Hypotension—Ramipril—hypertension	9.25e-06	0.000123	CcSEcCtD
Nadolol—Anorexia—Timolol—hypertension	9.22e-06	0.000122	CcSEcCtD
Nadolol—Pruritus—Telmisartan—hypertension	9.22e-06	0.000122	CcSEcCtD
Nadolol—Nausea—Eplerenone—hypertension	9.21e-06	0.000122	CcSEcCtD
Nadolol—Dry mouth—Lisinopril—hypertension	9.16e-06	0.000121	CcSEcCtD
Nadolol—Nausea—Nifedipine—hypertension	9.14e-06	0.000121	CcSEcCtD
Nadolol—Body temperature increased—Losartan—hypertension	9.12e-06	0.000121	CcSEcCtD
Nadolol—Nausea—Verapamil—hypertension	9.1e-06	0.000121	CcSEcCtD
Nadolol—Asthenia—Captopril—hypertension	9.09e-06	0.000121	CcSEcCtD
Nadolol—Diarrhoea—Trandolapril—hypertension	9.08e-06	0.00012	CcSEcCtD
Nadolol—Vomiting—Valsartan—hypertension	9.07e-06	0.00012	CcSEcCtD
Nadolol—Diarrhoea—Enalapril—hypertension	9.04e-06	0.00012	CcSEcCtD
Nadolol—Hypotension—Timolol—hypertension	9.04e-06	0.00012	CcSEcCtD
Nadolol—Vomiting—Olmesartan—hypertension	9.03e-06	0.00012	CcSEcCtD
Nadolol—Rash—Valsartan—hypertension	9e-06	0.000119	CcSEcCtD
Nadolol—Dizziness—Clonidine—hypertension	9e-06	0.000119	CcSEcCtD
Nadolol—Dermatitis—Valsartan—hypertension	8.99e-06	0.000119	CcSEcCtD
Nadolol—Oedema—Lisinopril—hypertension	8.98e-06	0.000119	CcSEcCtD
Nadolol—Pruritus—Captopril—hypertension	8.97e-06	0.000119	CcSEcCtD
Nadolol—Rash—Olmesartan—hypertension	8.95e-06	0.000119	CcSEcCtD
Nadolol—Insomnia—Ramipril—hypertension	8.95e-06	0.000119	CcSEcCtD
Nadolol—Dermatitis—Olmesartan—hypertension	8.95e-06	0.000119	CcSEcCtD
Nadolol—Diarrhoea—Telmisartan—hypertension	8.92e-06	0.000118	CcSEcCtD
Nadolol—Paraesthesia—Ramipril—hypertension	8.89e-06	0.000118	CcSEcCtD
Nadolol—Shock—Lisinopril—hypertension	8.83e-06	0.000117	CcSEcCtD
Nadolol—Asthenia—Perindopril—hypertension	8.83e-06	0.000117	CcSEcCtD
Nadolol—Dyspnoea—Ramipril—hypertension	8.82e-06	0.000117	CcSEcCtD
Nadolol—Asthenia—Irbesartan—hypertension	8.8e-06	0.000117	CcSEcCtD
Nadolol—Dizziness—Trandolapril—hypertension	8.77e-06	0.000116	CcSEcCtD
Nadolol—Insomnia—Timolol—hypertension	8.75e-06	0.000116	CcSEcCtD
Nadolol—Dizziness—Enalapril—hypertension	8.74e-06	0.000116	CcSEcCtD
Nadolol—Asthenia—Hydrochlorothiazide—hypertension	8.73e-06	0.000116	CcSEcCtD
Nadolol—Dyspepsia—Ramipril—hypertension	8.71e-06	0.000116	CcSEcCtD
Nadolol—Pruritus—Perindopril—hypertension	8.71e-06	0.000115	CcSEcCtD
Nadolol—Paraesthesia—Timolol—hypertension	8.69e-06	0.000115	CcSEcCtD
Nadolol—Pruritus—Irbesartan—hypertension	8.68e-06	0.000115	CcSEcCtD
Nadolol—Hyperhidrosis—Lisinopril—hypertension	8.68e-06	0.000115	CcSEcCtD
Nadolol—Diarrhoea—Captopril—hypertension	8.67e-06	0.000115	CcSEcCtD
Nadolol—Vomiting—Clonidine—hypertension	8.65e-06	0.000115	CcSEcCtD
Nadolol—Dyspnoea—Timolol—hypertension	8.63e-06	0.000114	CcSEcCtD
Nadolol—Dizziness—Telmisartan—hypertension	8.62e-06	0.000114	CcSEcCtD
Nadolol—Pruritus—Hydrochlorothiazide—hypertension	8.61e-06	0.000114	CcSEcCtD
Nadolol—Decreased appetite—Ramipril—hypertension	8.6e-06	0.000114	CcSEcCtD
Nadolol—Asthenia—Furosemide—hypertension	8.58e-06	0.000114	CcSEcCtD
Nadolol—Rash—Clonidine—hypertension	8.58e-06	0.000114	CcSEcCtD
Nadolol—Dermatitis—Clonidine—hypertension	8.57e-06	0.000114	CcSEcCtD
Nadolol—Anorexia—Lisinopril—hypertension	8.56e-06	0.000113	CcSEcCtD
Nadolol—Fatigue—Ramipril—hypertension	8.53e-06	0.000113	CcSEcCtD
Nadolol—Dyspepsia—Timolol—hypertension	8.52e-06	0.000113	CcSEcCtD
Nadolol—Asthenia—Betaxolol—hypertension	8.5e-06	0.000113	CcSEcCtD
Nadolol—Nausea—Valsartan—hypertension	8.48e-06	0.000112	CcSEcCtD
Nadolol—Pruritus—Furosemide—hypertension	8.46e-06	0.000112	CcSEcCtD
Nadolol—Constipation—Ramipril—hypertension	8.46e-06	0.000112	CcSEcCtD
Nadolol—Nausea—Olmesartan—hypertension	8.44e-06	0.000112	CcSEcCtD
Nadolol—Vomiting—Trandolapril—hypertension	8.44e-06	0.000112	CcSEcCtD
Nadolol—Diarrhoea—Perindopril—hypertension	8.42e-06	0.000112	CcSEcCtD
Nadolol—Decreased appetite—Timolol—hypertension	8.41e-06	0.000112	CcSEcCtD
Nadolol—Vomiting—Enalapril—hypertension	8.4e-06	0.000111	CcSEcCtD
Nadolol—Diarrhoea—Irbesartan—hypertension	8.39e-06	0.000111	CcSEcCtD
Nadolol—Hypotension—Lisinopril—hypertension	8.39e-06	0.000111	CcSEcCtD
Nadolol—Dizziness—Captopril—hypertension	8.38e-06	0.000111	CcSEcCtD
Nadolol—Pruritus—Betaxolol—hypertension	8.38e-06	0.000111	CcSEcCtD
Nadolol—Rash—Trandolapril—hypertension	8.37e-06	0.000111	CcSEcCtD
Nadolol—Dermatitis—Trandolapril—hypertension	8.36e-06	0.000111	CcSEcCtD
Nadolol—Fatigue—Timolol—hypertension	8.34e-06	0.000111	CcSEcCtD
Nadolol—Rash—Enalapril—hypertension	8.33e-06	0.00011	CcSEcCtD
Nadolol—Dermatitis—Enalapril—hypertension	8.32e-06	0.00011	CcSEcCtD
Nadolol—Diarrhoea—Hydrochlorothiazide—hypertension	8.32e-06	0.00011	CcSEcCtD
Nadolol—Vomiting—Telmisartan—hypertension	8.29e-06	0.00011	CcSEcCtD
Nadolol—Asthenia—Losartan—hypertension	8.28e-06	0.00011	CcSEcCtD
Nadolol—Pain—Timolol—hypertension	8.27e-06	0.00011	CcSEcCtD
Nadolol—Rash—Telmisartan—hypertension	8.22e-06	0.000109	CcSEcCtD
Nadolol—Dermatitis—Telmisartan—hypertension	8.21e-06	0.000109	CcSEcCtD
Nadolol—Diarrhoea—Furosemide—hypertension	8.18e-06	0.000109	CcSEcCtD
Nadolol—Pruritus—Losartan—hypertension	8.17e-06	0.000108	CcSEcCtD
Nadolol—Dizziness—Perindopril—hypertension	8.14e-06	0.000108	CcSEcCtD
Nadolol—Insomnia—Lisinopril—hypertension	8.12e-06	0.000108	CcSEcCtD
Nadolol—Dizziness—Irbesartan—hypertension	8.11e-06	0.000108	CcSEcCtD
Nadolol—Diarrhoea—Betaxolol—hypertension	8.1e-06	0.000107	CcSEcCtD
Nadolol—Nausea—Clonidine—hypertension	8.08e-06	0.000107	CcSEcCtD
Nadolol—Paraesthesia—Lisinopril—hypertension	8.06e-06	0.000107	CcSEcCtD
Nadolol—Vomiting—Captopril—hypertension	8.06e-06	0.000107	CcSEcCtD
Nadolol—Dizziness—Hydrochlorothiazide—hypertension	8.04e-06	0.000107	CcSEcCtD
Nadolol—Dyspnoea—Lisinopril—hypertension	8e-06	0.000106	CcSEcCtD
Nadolol—Rash—Captopril—hypertension	7.99e-06	0.000106	CcSEcCtD
Nadolol—Dermatitis—Captopril—hypertension	7.98e-06	0.000106	CcSEcCtD
Nadolol—Dizziness—Furosemide—hypertension	7.91e-06	0.000105	CcSEcCtD
Nadolol—Dyspepsia—Lisinopril—hypertension	7.9e-06	0.000105	CcSEcCtD
Nadolol—Diarrhoea—Losartan—hypertension	7.9e-06	0.000105	CcSEcCtD
Nadolol—Nausea—Trandolapril—hypertension	7.88e-06	0.000105	CcSEcCtD
Nadolol—Nausea—Enalapril—hypertension	7.85e-06	0.000104	CcSEcCtD
Nadolol—Dizziness—Betaxolol—hypertension	7.83e-06	0.000104	CcSEcCtD
Nadolol—Vomiting—Perindopril—hypertension	7.82e-06	0.000104	CcSEcCtD
Nadolol—Body temperature increased—Ramipril—hypertension	7.82e-06	0.000104	CcSEcCtD
Nadolol—Decreased appetite—Lisinopril—hypertension	7.8e-06	0.000103	CcSEcCtD
Nadolol—Vomiting—Irbesartan—hypertension	7.8e-06	0.000103	CcSEcCtD
Nadolol—Rash—Perindopril—hypertension	7.76e-06	0.000103	CcSEcCtD
Nadolol—Dermatitis—Perindopril—hypertension	7.75e-06	0.000103	CcSEcCtD
Nadolol—Nausea—Telmisartan—hypertension	7.74e-06	0.000103	CcSEcCtD
Nadolol—Fatigue—Lisinopril—hypertension	7.74e-06	0.000103	CcSEcCtD
Nadolol—Vomiting—Hydrochlorothiazide—hypertension	7.73e-06	0.000103	CcSEcCtD
Nadolol—Rash—Irbesartan—hypertension	7.73e-06	0.000103	CcSEcCtD
Nadolol—Dermatitis—Irbesartan—hypertension	7.73e-06	0.000102	CcSEcCtD
Nadolol—Pain—Lisinopril—hypertension	7.68e-06	0.000102	CcSEcCtD
Nadolol—Constipation—Lisinopril—hypertension	7.68e-06	0.000102	CcSEcCtD
Nadolol—Rash—Hydrochlorothiazide—hypertension	7.67e-06	0.000102	CcSEcCtD
Nadolol—Dermatitis—Hydrochlorothiazide—hypertension	7.66e-06	0.000102	CcSEcCtD
Nadolol—Body temperature increased—Timolol—hypertension	7.65e-06	0.000101	CcSEcCtD
Nadolol—Dizziness—Losartan—hypertension	7.63e-06	0.000101	CcSEcCtD
Nadolol—Vomiting—Furosemide—hypertension	7.61e-06	0.000101	CcSEcCtD
Nadolol—Rash—Furosemide—hypertension	7.54e-06	0.0001	CcSEcCtD
Nadolol—Dermatitis—Furosemide—hypertension	7.54e-06	9.99e-05	CcSEcCtD
Nadolol—Vomiting—Betaxolol—hypertension	7.53e-06	9.99e-05	CcSEcCtD
Nadolol—Nausea—Captopril—hypertension	7.53e-06	9.98e-05	CcSEcCtD
Nadolol—Rash—Betaxolol—hypertension	7.47e-06	9.9e-05	CcSEcCtD
Nadolol—Dermatitis—Betaxolol—hypertension	7.46e-06	9.89e-05	CcSEcCtD
Nadolol—Vomiting—Losartan—hypertension	7.34e-06	9.73e-05	CcSEcCtD
Nadolol—Nausea—Perindopril—hypertension	7.31e-06	9.69e-05	CcSEcCtD
Nadolol—Nausea—Irbesartan—hypertension	7.28e-06	9.66e-05	CcSEcCtD
Nadolol—Rash—Losartan—hypertension	7.28e-06	9.65e-05	CcSEcCtD
Nadolol—Dermatitis—Losartan—hypertension	7.27e-06	9.64e-05	CcSEcCtD
Nadolol—Nausea—Hydrochlorothiazide—hypertension	7.23e-06	9.58e-05	CcSEcCtD
Nadolol—Nausea—Furosemide—hypertension	7.11e-06	9.42e-05	CcSEcCtD
Nadolol—Asthenia—Ramipril—hypertension	7.1e-06	9.42e-05	CcSEcCtD
Nadolol—Body temperature increased—Lisinopril—hypertension	7.1e-06	9.41e-05	CcSEcCtD
Nadolol—Nausea—Betaxolol—hypertension	7.03e-06	9.33e-05	CcSEcCtD
Nadolol—Pruritus—Ramipril—hypertension	7e-06	9.29e-05	CcSEcCtD
Nadolol—Asthenia—Timolol—hypertension	6.94e-06	9.21e-05	CcSEcCtD
Nadolol—Nausea—Losartan—hypertension	6.86e-06	9.09e-05	CcSEcCtD
Nadolol—Pruritus—Timolol—hypertension	6.84e-06	9.08e-05	CcSEcCtD
Nadolol—Diarrhoea—Ramipril—hypertension	6.77e-06	8.98e-05	CcSEcCtD
Nadolol—Diarrhoea—Timolol—hypertension	6.62e-06	8.78e-05	CcSEcCtD
Nadolol—Dizziness—Ramipril—hypertension	6.54e-06	8.68e-05	CcSEcCtD
Nadolol—Asthenia—Lisinopril—hypertension	6.44e-06	8.54e-05	CcSEcCtD
Nadolol—Dizziness—Timolol—hypertension	6.4e-06	8.48e-05	CcSEcCtD
Nadolol—Pruritus—Lisinopril—hypertension	6.35e-06	8.42e-05	CcSEcCtD
Nadolol—Vomiting—Ramipril—hypertension	6.29e-06	8.34e-05	CcSEcCtD
Nadolol—Rash—Ramipril—hypertension	6.24e-06	8.28e-05	CcSEcCtD
Nadolol—Dermatitis—Ramipril—hypertension	6.23e-06	8.27e-05	CcSEcCtD
Nadolol—Vomiting—Timolol—hypertension	6.15e-06	8.16e-05	CcSEcCtD
Nadolol—Diarrhoea—Lisinopril—hypertension	6.14e-06	8.14e-05	CcSEcCtD
Nadolol—Rash—Timolol—hypertension	6.1e-06	8.09e-05	CcSEcCtD
Nadolol—Dermatitis—Timolol—hypertension	6.09e-06	8.08e-05	CcSEcCtD
Nadolol—Dizziness—Lisinopril—hypertension	5.94e-06	7.87e-05	CcSEcCtD
Nadolol—Nausea—Ramipril—hypertension	5.88e-06	7.8e-05	CcSEcCtD
Nadolol—Nausea—Timolol—hypertension	5.75e-06	7.62e-05	CcSEcCtD
Nadolol—Vomiting—Lisinopril—hypertension	5.71e-06	7.57e-05	CcSEcCtD
Nadolol—Rash—Lisinopril—hypertension	5.66e-06	7.5e-05	CcSEcCtD
Nadolol—Dermatitis—Lisinopril—hypertension	5.65e-06	7.5e-05	CcSEcCtD
Nadolol—Nausea—Lisinopril—hypertension	5.33e-06	7.07e-05	CcSEcCtD
Nadolol—ADRB1—Signaling Pathways—CXCL10—hypertension	2.05e-06	6.12e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL2—hypertension	2.05e-06	6.12e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLG—hypertension	2.04e-06	6.1e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HSPG2—hypertension	2.04e-06	6.1e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—RHOA—hypertension	2.04e-06	6.09e-05	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—PPARA—hypertension	2.02e-06	6.04e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—STK11—hypertension	2.02e-06	6.04e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HDAC1—hypertension	2.02e-06	6.04e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT2—hypertension	2.02e-06	6.04e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PIK3R1—hypertension	2.02e-06	6.03e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1—hypertension	2.01e-06	6.01e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL2—hypertension	2.01e-06	6.01e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT2—hypertension	2.01e-06	6.01e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL10—hypertension	2.01e-06	5.99e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—EGFR—hypertension	2e-06	5.98e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLG—hypertension	2e-06	5.97e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—RHOA—hypertension	2e-06	5.96e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRB2—hypertension	1.99e-06	5.94e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT2—hypertension	1.98e-06	5.91e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PIK3R1—hypertension	1.98e-06	5.9e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALOX5—hypertension	1.97e-06	5.89e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GLP1R—hypertension	1.97e-06	5.89e-05	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hypertension	1.97e-06	5.89e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCE—hypertension	1.97e-06	5.87e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PDGFA—hypertension	1.94e-06	5.79e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VAV3—hypertension	1.94e-06	5.79e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCE—hypertension	1.92e-06	5.74e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFBR2—hypertension	1.91e-06	5.71e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SERPINE1—hypertension	1.91e-06	5.71e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PDGFA—hypertension	1.9e-06	5.67e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VAV3—hypertension	1.9e-06	5.67e-05	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—APOA1—hypertension	1.9e-06	5.67e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GNB3—hypertension	1.9e-06	5.66e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFBR2—hypertension	1.87e-06	5.59e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AVP—hypertension	1.87e-06	5.58e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GNB3—hypertension	1.85e-06	5.54e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—RHOA—hypertension	1.85e-06	5.53e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FGF2—hypertension	1.85e-06	5.53e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GNAS—hypertension	1.85e-06	5.51e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RHOA—hypertension	1.84e-06	5.51e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PIK3R1—hypertension	1.83e-06	5.48e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AVP—hypertension	1.83e-06	5.46e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOS3—hypertension	1.83e-06	5.45e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PIK3R1—hypertension	1.83e-06	5.45e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—RHOA—hypertension	1.81e-06	5.41e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOB—hypertension	1.81e-06	5.4e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GNAS—hypertension	1.81e-06	5.39e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALDH2—hypertension	1.8e-06	5.39e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PTK2—hypertension	1.8e-06	5.37e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PIK3R1—hypertension	1.79e-06	5.36e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL8—hypertension	1.79e-06	5.35e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EDN1—hypertension	1.78e-06	5.31e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOB—hypertension	1.77e-06	5.28e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL5—hypertension	1.76e-06	5.27e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PTK2—hypertension	1.76e-06	5.26e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HBA1—hypertension	1.76e-06	5.25e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL8—hypertension	1.75e-06	5.23e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP11A1—hypertension	1.75e-06	5.22e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EDN1—hypertension	1.74e-06	5.19e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL5—hypertension	1.73e-06	5.15e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LPL—hypertension	1.73e-06	5.15e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RELA—hypertension	1.72e-06	5.13e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTT1—hypertension	1.72e-06	5.12e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC9A1—hypertension	1.72e-06	5.12e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—H2AFX—hypertension	1.71e-06	5.12e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PDGFRB—hypertension	1.71e-06	5.11e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RPS6KB1—hypertension	1.71e-06	5.11e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCLC—hypertension	1.7e-06	5.06e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CETP—hypertension	1.7e-06	5.06e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADCY5—hypertension	1.69e-06	5.04e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LPL—hypertension	1.69e-06	5.04e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MTOR—hypertension	1.69e-06	5.03e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCG—hypertension	1.68e-06	5.01e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—H2AFX—hypertension	1.68e-06	5e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RPS6KB1—hypertension	1.67e-06	4.99e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PDGFRB—hypertension	1.67e-06	4.99e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCA—hypertension	1.67e-06	4.98e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ITGB3—hypertension	1.67e-06	4.98e-05	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	1.67e-06	4.97e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—YWHAZ—hypertension	1.65e-06	4.94e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADCY5—hypertension	1.65e-06	4.93e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCG—hypertension	1.64e-06	4.9e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SPP1—hypertension	1.63e-06	4.88e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NGF—hypertension	1.63e-06	4.88e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ITGB3—hypertension	1.63e-06	4.87e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCA—hypertension	1.63e-06	4.87e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL8—hypertension	1.63e-06	4.86e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP17A1—hypertension	1.62e-06	4.85e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL8—hypertension	1.62e-06	4.84e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—YWHAZ—hypertension	1.62e-06	4.83e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ENO1—hypertension	1.61e-06	4.8e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS1—hypertension	1.61e-06	4.8e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SPP1—hypertension	1.6e-06	4.77e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NGF—hypertension	1.6e-06	4.77e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL8—hypertension	1.59e-06	4.75e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCD—hypertension	1.59e-06	4.75e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR5—hypertension	1.59e-06	4.75e-05	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AKT1—hypertension	1.56e-06	4.67e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—hypertension	1.56e-06	4.65e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCD—hypertension	1.56e-06	4.64e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR5—hypertension	1.56e-06	4.64e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—C3—hypertension	1.55e-06	4.64e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CTGF—hypertension	1.55e-06	4.62e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—hypertension	1.54e-06	4.6e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMGCR—hypertension	1.53e-06	4.58e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT2—hypertension	1.53e-06	4.58e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—hypertension	1.52e-06	4.54e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—C3—hypertension	1.52e-06	4.54e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PDGFB—hypertension	1.51e-06	4.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGFR1—hypertension	1.5e-06	4.49e-05	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—hypertension	1.5e-06	4.49e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADRA2A—hypertension	1.5e-06	4.48e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.48e-06	4.42e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.48e-06	4.42e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AGT—hypertension	1.48e-06	4.41e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.47e-06	4.39e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP9—hypertension	1.46e-06	4.37e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CDKN1A—hypertension	1.46e-06	4.36e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PTEN—hypertension	1.46e-06	4.35e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CALM1—hypertension	1.45e-06	4.33e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.45e-06	4.33e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LEP—hypertension	1.45e-06	4.32e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—hypertension	1.45e-06	4.32e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AGT—hypertension	1.44e-06	4.31e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CAV1—hypertension	1.43e-06	4.28e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOA1—hypertension	1.43e-06	4.27e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MAPK8—hypertension	1.42e-06	4.25e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AKT1—hypertension	1.42e-06	4.24e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CALM1—hypertension	1.42e-06	4.24e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KDR—hypertension	1.42e-06	4.23e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LEP—hypertension	1.42e-06	4.22e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—hypertension	1.42e-06	4.22e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TH—hypertension	1.41e-06	4.2e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CAV1—hypertension	1.4e-06	4.19e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CALM2—hypertension	1.4e-06	4.18e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOA1—hypertension	1.4e-06	4.18e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EP300—hypertension	1.39e-06	4.15e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KDR—hypertension	1.39e-06	4.14e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCG—hypertension	1.37e-06	4.08e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC2A4—hypertension	1.37e-06	4.08e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.36e-06	4.07e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—F2—hypertension	1.36e-06	4.07e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FN1—hypertension	1.36e-06	4.07e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SRC—hypertension	1.35e-06	4.03e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.34e-06	3.99e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FN1—hypertension	1.33e-06	3.98e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—F2—hypertension	1.33e-06	3.98e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.33e-06	3.98e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT1—hypertension	1.32e-06	3.95e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—VEGFA—hypertension	1.32e-06	3.93e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.31e-06	3.9e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—STK11—hypertension	1.29e-06	3.84e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP19A1—hypertension	1.29e-06	3.84e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—POMC—hypertension	1.24e-06	3.71e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—INS—hypertension	1.24e-06	3.69e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL2—hypertension	1.22e-06	3.63e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—POMC—hypertension	1.22e-06	3.63e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MYC—hypertension	1.21e-06	3.61e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—INS—hypertension	1.21e-06	3.61e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFB1—hypertension	1.21e-06	3.6e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1—hypertension	1.2e-06	3.57e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—COMT—hypertension	1.2e-06	3.57e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT2—hypertension	1.19e-06	3.57e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—EGFR—hypertension	1.19e-06	3.55e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL2—hypertension	1.19e-06	3.55e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EGFR—hypertension	1.18e-06	3.53e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GNB3—hypertension	1.18e-06	3.52e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARGC1A—hypertension	1.18e-06	3.52e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMOX1—hypertension	1.17e-06	3.5e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1—hypertension	1.17e-06	3.49e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT2—hypertension	1.17e-06	3.49e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—EGFR—hypertension	1.16e-06	3.47e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAT—hypertension	1.16e-06	3.46e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GNAS—hypertension	1.15e-06	3.43e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SERPINE1—hypertension	1.14e-06	3.39e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOB—hypertension	1.12e-06	3.35e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SERPINE1—hypertension	1.11e-06	3.32e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGF2—hypertension	1.1e-06	3.28e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RHOA—hypertension	1.1e-06	3.27e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTM1—hypertension	1.09e-06	3.26e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOS3—hypertension	1.08e-06	3.24e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PIK3R1—hypertension	1.08e-06	3.24e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGF2—hypertension	1.07e-06	3.21e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LPL—hypertension	1.07e-06	3.2e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RHOA—hypertension	1.07e-06	3.2e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PIK3R1—hypertension	1.06e-06	3.16e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOS3—hypertension	1.06e-06	3.16e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADCY5—hypertension	1.05e-06	3.14e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GPX1—hypertension	1.05e-06	3.13e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PRKCA—hypertension	1.04e-06	3.09e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP1A1—hypertension	1.04e-06	3.09e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RELA—hypertension	1.02e-06	3.05e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CD36—hypertension	1.02e-06	3.04e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MTOR—hypertension	1e-06	2.99e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RELA—hypertension	9.98e-07	2.98e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TP53—hypertension	9.94e-07	2.97e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MTOR—hypertension	9.79e-07	2.92e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MTHFR—hypertension	9.66e-07	2.88e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL8—hypertension	9.61e-07	2.87e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARA—hypertension	9.48e-07	2.83e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL8—hypertension	9.4e-07	2.81e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AKT1—hypertension	9.29e-07	2.77e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AGT—hypertension	9.18e-07	2.74e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—hypertension	9.14e-07	2.73e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—hypertension	9.1e-07	2.72e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AKT1—hypertension	9.08e-07	2.71e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CALM1—hypertension	9.03e-07	2.69e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—hypertension	8.99e-07	2.68e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—hypertension	8.94e-07	2.67e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAV1—hypertension	8.91e-07	2.66e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOA1—hypertension	8.89e-07	2.65e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP9—hypertension	8.7e-07	2.6e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CDKN1A—hypertension	8.66e-07	2.59e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PTEN—hypertension	8.64e-07	2.58e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP9—hypertension	8.51e-07	2.54e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CDKN1A—hypertension	8.48e-07	2.53e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAPK8—hypertension	8.46e-07	2.52e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PTEN—hypertension	8.46e-07	2.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT1—hypertension	8.43e-07	2.52e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT1—hypertension	8.39e-07	2.51e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAPK8—hypertension	8.27e-07	2.47e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT1—hypertension	8.25e-07	2.46e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EP300—hypertension	8.24e-07	2.46e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EP300—hypertension	8.06e-07	2.41e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SRC—hypertension	8.02e-07	2.39e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SRC—hypertension	7.84e-07	2.34e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARG—hypertension	7.83e-07	2.34e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VEGFA—hypertension	7.81e-07	2.33e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—POMC—hypertension	7.73e-07	2.31e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—INS—hypertension	7.68e-07	2.29e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VEGFA—hypertension	7.64e-07	2.28e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MYC—hypertension	7.18e-07	2.14e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFB1—hypertension	7.17e-07	2.14e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—hypertension	7.04e-07	2.1e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MYC—hypertension	7.03e-07	2.1e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EGFR—hypertension	7.03e-07	2.1e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFB1—hypertension	7.01e-07	2.09e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EGFR—hypertension	6.87e-07	2.05e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PIK3R1—hypertension	6.74e-07	2.01e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NOS3—hypertension	6.74e-07	2.01e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—hypertension	6.16e-07	1.84e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TP53—hypertension	5.9e-07	1.76e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TP53—hypertension	5.77e-07	1.72e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—hypertension	5.4e-07	1.61e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTEN—hypertension	5.37e-07	1.6e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—hypertension	5.28e-07	1.58e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—EP300—hypertension	5.13e-07	1.53e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT1—hypertension	4.98e-07	1.49e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT1—hypertension	4.87e-07	1.45e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AKT1—hypertension	3.1e-07	9.25e-06	CbGpPWpGaD
